Highest-materiality recent filing
Elected Thomas Bohjalian, David Henry, Constance Moore, Glenn Rufrano, Peter Scott, Donald Wood; each received >90% of votes cast.
Healthcare Realty Trust enters $400M unsecured delayed draw term loan facility due 2029
Term Loan Agreement provides $400M senior unsecured delayed draw term loan, available until May 2027.
HR subsidiary issues $700M 3.00% exchangeable senior notes due 2032
Issued $700M aggregate principal of 3.00% exchangeable notes due Jan 15, 2032; initial exchange price ~$23.01/share.
Healthcare Realty prices upsized $600M exchangeable notes at 3.00%, repays 2026 notes
Offer upsized from $500M to $600M; initial purchasers have option for additional $100M.
Healthcare Realty Q1 Normalized FFO $0.41; raises FY 2026 guidance on strong leasing
GAAP net loss improved to $(0.00)/share from $(0.13) YoY; Normalized FFO $0.41 (vs $0.39 prior year).
Normalized FFO per share $1.61, up 3% YoY; same-store cash NOI growth 4.8% (vs 3.5%–4.5% guidance midpoint).
Healthcare Realty Trust replaces BDO with Deloitte as independent auditor
Audit Committee replaced BDO USA with Deloitte & Touche effective February 19, 2026.
Healthcare Realty Q4 NAREIT FFO $0.36/sh; guides 2026 Normalized FFO $1.58-$1.64
GAAP net income $0.04/sh (Q4); full-year GAAP net loss $(0.71)/sh on $246M loss.
Healthcare Realty Trust appoints Daniel Gabbay as CFO; Austen Helfrich departs
Daniel Gabbay named EVP and CFO effective Jan 12, 2026; previously MD at RBC Capital Markets covering healthcare REITs.
Healthcare Realty Trust launches up to $1B ATM equity offering program with 16 sales agents
Equity Distribution Agreements allow sale of up to $1B of Class A common stock from time to time in at-the-market offerings.
Healthcare Realty Q3 Normalized FFO $0.41, raises 2025 guidance, $404M asset sales closed
GAAP net loss ($0.17)/shr vs ($0.26) YoY; Normalized FFO $0.41, NAREIT FFO $0.34.
Healthcare Realty enters $2.615B credit facility, extends revolver maturity to 2029
$1.5B unsecured revolver extended from Oct 2025 to July 2029, with two six-month extension options.
Healthcare Realty reports Q2 GAAP loss of $0.45/share; cuts dividend 23%, raises NFFO guidance
GAAP net loss of $(0.45) per share vs $(0.39) in Q2 2024; Normalized FFO $0.41 per share.
Healthcare Realty board reduced from 12 to 7 after five directors retire
Nancy Agee, Ajay Gupta, James Kilroy, Peter Lyle, Christann Vasquez retired June 18, 2025.
Healthcare Realty adds CEO Peter Scott to Board; annual meeting results
Peter A. Scott, President & CEO since April 15, 2025, appointed to Board; size increased to 12 directors with planned reduction.
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”) approved the appointment of Peter A. Scott to serve as a director.
Max materiality 0.85 · Median 0.65 · Most common event earnings